Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kouides

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Thrombosis and Haemostasis : JTH|May 2, 2015
Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis NetworkT Abshire, J Cox-Gill, C L Kempton, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 19, 2009
Emerging clinical concerns in the ageing haemophilia patientB A Konkle, C Kessler, L Aledort, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 22, 2014
Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxisA H James, B A Konkle, P Kouides, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2016
Use of donated clotting factors for surgeries on haemophilic patients in a resource-constrained country: a kind donor, good outcome, change of practice and future directionsB S Poudyal, G S Shrestha, S Tuladhar, et al.
Journal of Thrombosis and Haemostasis : JTH|September 3, 2011
The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experienceM Kurth, J Puetz, P Kouides, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 27, 2017
Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disordersC E Walsh, K Workowski, N A Terrault, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Thrombosis and Haemostasis : JTH|May 2, 2015
Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis NetworkT Abshire, J Cox-Gill, C L Kempton, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 19, 2009
Emerging clinical concerns in the ageing haemophilia patientB A Konkle, C Kessler, L Aledort, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 22, 2014
Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxisA H James, B A Konkle, P Kouides, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2016
Use of donated clotting factors for surgeries on haemophilic patients in a resource-constrained country: a kind donor, good outcome, change of practice and future directionsB S Poudyal, G S Shrestha, S Tuladhar, et al.
Journal of Thrombosis and Haemostasis : JTH|September 3, 2011
The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experienceM Kurth, J Puetz, P Kouides, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 27, 2017
Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disordersC E Walsh, K Workowski, N A Terrault, et al.
Pageof 2